Evaluation of Satisfaction and Grievances Regarding Treatment in HBV and HCV Patients

<p>Introduction: Chronic hepatitis B (HBV) & C Virus (HCV) infection are important cause of cirrhosis of liver for which <br>effective treatment is available but still significant number of patients require liver transplantation when it reaches end stage <br>liver disease. HBV patients in two-third of cases are in inactive carrier stage whereas in one-third cases they are in chronic <br>phase or in cirrhotic stage but in both cases require life-long follow-up. In contrast to HBV, HCV patients require 12-24 <br>weeks treatment and who achieve sustained virological response (SVR) do not require follow-up, except in cirrhotic patients <br>who remain on life-long follow up. There are limited studies in literature determining satisfactory index of HBV &HCV <br>patients with treatment given to them, hardships faced during treatment and remedies for the same. familial prevalence in <br>HCV patient.  </p>